Your browser doesn't support javascript.
loading
Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma.
Wang, Michael L; Jurczak, Wojciech; Zinzani, Pier Luigi; Eyre, Toby A; Cheah, Chan Y; Ujjani, Chaitra S; Koh, Youngil; Izutsu, Koji; Gerson, James N; Flinn, Ian; Tessoulin, Benoit; Alencar, Alvaro J; Ma, Shuo; Lewis, David; Lech-Maranda, Ewa; Rhodes, Joanna; Patel, Krish; Maddocks, Kami; Lamanna, Nicole; Wang, Yucai; Tam, Constantine S; Munir, Talha; Nagai, Hirokazu; Hernandez-Ilizaliturri, Francisco; Kumar, Anita; Fenske, Timothy S; Seymour, John F; Zelenetz, Andrew D; Nair, Binoj; Tsai, Donald E; Balbas, Minna; Walgren, Richard A; Abada, Paolo; Wang, Chunxiao; Zhao, Junjie; Mato, Anthony R; Shah, Nirav N.
Affiliation
  • Wang ML; MD Anderson Cancer Center, Houston, TX.
  • Jurczak W; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland.
  • Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia "Seràgnoli," Bologna, Italy.
  • Eyre TA; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy.
  • Cheah CY; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Center, Oxford, United Kingdom.
  • Ujjani CS; Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, WA, Australia.
  • Koh Y; Medical School, University of Western Australia, Perth, WA, Australia.
  • Izutsu K; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.
  • Gerson JN; Seoul National University Hospital, Seoul, Korea.
  • Flinn I; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Tessoulin B; University of Vermont, Burlington, VT.
  • Alencar AJ; Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN.
  • Ma S; Haematology Department, University Hospital, Nantes, France.
  • Lewis D; Sylvester Comprehensive Cancer Center, Miami, FL.
  • Lech-Maranda E; Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL.
  • Rhodes J; Plymouth Hospitals NHS Trust-Derriford Hospital, Plymouth, United Kingdom.
  • Patel K; Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Maddocks K; Donald and Barbara Zucker School of Medicine at Northwell/Hofstra, Uniondale, NY.
  • Lamanna N; Northwell Health Cancer Institute Lake Success, New Hyde Park, NY.
  • Wang Y; Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, WA.
  • Tam CS; The Ohio State University Comprehensive Cancer Center, Columbus, OH.
  • Munir T; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY.
  • Nagai H; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Hernandez-Ilizaliturri F; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, Australia.
  • Kumar A; Department of Haematology, St James's University Hospital, Leeds, United Kingdom.
  • Fenske TS; Department of Hematology, National Hospital Organization Nagoya Medical Center, Aichi, Japan.
  • Seymour JF; Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Zelenetz AD; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Nair B; Medical College of Wisconsin, Milwaukee, WI.
  • Tsai DE; Peter MacCallum Cancer Centre, Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, Australia.
  • Balbas M; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Walgren RA; Loxo@Lilly, Indianapolis, IN.
  • Abada P; Loxo@Lilly, Indianapolis, IN.
  • Wang C; Loxo@Lilly, Indianapolis, IN.
  • Zhao J; Loxo@Lilly, Indianapolis, IN.
  • Mato AR; Loxo@Lilly, Indianapolis, IN.
  • Shah NN; Eli Lilly and Company, Indianapolis, IN.
J Clin Oncol ; 41(24): 3988-3997, 2023 08 20.
Article in En | MEDLINE | ID: mdl-37192437

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Mantle-Cell Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Mantle-Cell Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Aged / Aged80 / Humans / Middle aged Language: En Journal: J Clin Oncol Year: 2023 Document type: Article Country of publication: